Inovio Pharmaceuticals
Utility Patent Applications

Last updated:

List of all Inovio Pharmaceuticals patents 40 in total

Status Patent
Application
Utility: Cancer Vaccines Targeting PRAME and Uses Thereof External link
Filling date: 7 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: CANCER VACCINES TARGETING LEMD1 AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: MINIMALLY INVASIVE DERMAL ELECTROPORATION DEVICE External link
Filling date: 7 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: ELECTROPORATION DEVICE HAVING A BATTERY PACK WITH POWER SWITCH External link
Filling date: 7 Sep 2025 Issue date: 16 Jun 2022
Application
Utility: DNA ANTIBODY CONSTRUCTS FOR USE AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS External link
Filling date: 7 Sep 2025 Issue date: 14 Apr 2022
Application
Utility: CANCER VACCINES TARGETING MUC16 AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 14 Apr 2022
Application
Utility: DNA Antibody Constructs And Method Of Using Same External link
Filling date: 7 Sep 2025 Issue date: 14 Apr 2022
Application
Utility: Consensus Prostate Antigens, Nucleic Acid Molecule Encoding The Same And Vaccine And Uses Comprising The Same External link
Filling date: 7 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: Foot and Mouth Disease Virus (FMDV) Consensus Proteins, Coding Sequences Therefor and Vaccines Made Therefrom External link
Filling date: 7 Sep 2025 Issue date: 13 Jan 2022
Application
Utility: MERS-CoV Vaccine External link
Filling date: 7 Sep 2025 Issue date: 30 Dec 2021
Application
Utility: CANCER VACCINES TARGETING MESOTHELIN AND USES THEREOF External link
Filling date: 7 Sep 2025 Issue date: 30 Dec 2021
Application
Utility: Filovirus Consensus Antigens, Nucleic Acid Constructs and Vaccines Made Therefrom, and Methods of Using Same External link
Filling date: 7 Sep 2025 Issue date: 16 Dec 2021
Application
Utility: TUMOR-SPECIFIC NEOANTIGENS AND METHODS OF USING THE SAME External link
Filling date: 7 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: Multiple Tissue Layer Electroporation Applicator and Device External link
Filling date: 7 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The Same External link
Filling date: 7 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: ELECTROPORATION DEVICE WITH DETACHABLE NEEDLE ARRAY WITH LOCK-OUT SYSTEM External link
Filling date: 7 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: Vacuum-Assisted Electroporation Devices, And Related Systems And Methods External link
Filling date: 7 Sep 2025 Issue date: 23 Sep 2021
Application
Utility: Cancer Vaccines and Methods of Treatment Using The Same External link
Filling date: 7 Sep 2025 Issue date: 2 Sep 2021
Application
Utility: VACCINES AGAINST CORONAVIRUS AND METHODS OF USE External link
Filling date: 7 Sep 2025 Issue date: 2 Sep 2021
Application
Utility: INTRADERMAL JET INJECTION ELECTROPORATION External link
Filling date: 7 Sep 2025 Issue date: 26 Aug 2021
Application
Utility: VACCINES HAVING AN ANTIGEN AND INTERLEUKIN-21 AS AN ADJUVANT External link
Filling date: 7 Sep 2025 Issue date: 5 Aug 2021
Application
Utility: VACCINES WITH INTERLEUKIN-33 AS AN ADJUVANT External link
Filling date: 7 Sep 2025 Issue date: 1 Jul 2021
Application
Utility: OPTIMIZED NUCLEIC ACID ANTIBODY CONSTRUCTS External link
Filling date: 7 Sep 2025 Issue date: 24 Jun 2021
Application
Utility: ELECTROPORATION DEVICE HAVING A BATTERY PACK WITH POWER SWITCH External link
Filling date: 7 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: Oral Mucosal Electroporation Device and Use Thereof External link
Filling date: 7 Sep 2025 Issue date: 20 May 2021
Application
Utility: Vaccines For Human Papilloma Virus And Methods For Using The Same External link
Filling date: 7 Sep 2025 Issue date: 29 Apr 2021
Application
Utility: DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HIV External link
Filling date: 7 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: PD1 AND PDL1 ANTIBODIES AND VACCINE COMBINATIONS AND USE OF SAME FOR IMMUNOTHERAPY External link
Filling date: 7 Sep 2025 Issue date: 25 Mar 2021
Application
Utility: NUCLEIC ACID ANTIBODY CONSTRUCTS FOR USE AGAINST RESPIRATORY SYNCYTIAL VIRUS External link
Filling date: 7 Sep 2025 Issue date: 18 Feb 2021
Application
Utility: DNA ANTIBODY CONSTRUCTS FOR USE AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS External link
Filling date: 7 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: CLINICAL AND IMMUNOLOGIC BIOMARKERS FOR REGRESSION OF HIGH GRADE CERVICAL DYSPLASIA AND CLEARANCE OF HPV16 AND HPV18 INFECTION AFTER IMMUNOTHERAPY External link
Filling date: 7 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: MINIMALLY INVASIVE DERMAL ELECTROPORATION DEVICE External link
Filling date: 7 Sep 2025 Issue date: 6 Aug 2020
Application
Utility: MERS-CoV Vaccine External link
Filling date: 7 Sep 2025 Issue date: 16 Jul 2020
Application
Utility: TERT IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME External link
Filling date: 7 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: Foot and Mouth Disease Virus (FMDV) Consensus Proteins, Coding Sequences Therefor and Vaccines Made Therefrom External link
Filling date: 7 Sep 2025 Issue date: 16 Jan 2020
Application
Utility: METHOD AND DEVICE FOR MINIMALLY INVASIVE IN VIVO TRANSFECTION OF ADIPOSE TISSUE USING ELECTROPORATION External link
Filling date: 7 Sep 2025 Issue date: 16 Jan 2020
Application
Utility: Electroporation Device and Injection Apparatus External link
Filling date: 7 Sep 2025 Issue date: 21 Nov 2019
Application
Utility: SYNTHETIC MALARIA IMMUNOGENS, COMBINATIONS THEREOF, AND THEIR USE TO PREVENT AND TREAT MALARIA INFECTIONS External link
Filling date: 7 Sep 2025 Issue date: 10 Oct 2019
Application
Utility: IN VIVO USE OF CHONDROITINASE AND/OR HYALURONIDASE TO ENHANCE DELIVERY OF AN AGENT External link
Filling date: 7 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: WT1 Vaccine External link
Filling date: 7 Sep 2025 Issue date: 22 Aug 2019

Showing 1 to 40 of 40 patents.